Printer Friendly

Exploring the Urtica dioica Leaves Hemostatic and Wound-Healing Potential.

1. Introduction

The extraction and characterization of bioactive molecules from plants have opened new horizons to the development of pharmacological targets to reduce the marked adverse effects of chemical agents. Wound care medicinal plants have been in use since ancient civilizations. Plant extracts are well known in dermopharmacy for their abilities to promote wound healing via different molecular pathways such as the antioxidant and the antibacterial activities [1].

Wound healing is essential for the restoration of disturbed skin anatomical continuity. It involves different overlapping phases including inflammation, wound contraction, and reepithelialization with neovascularization [2]. Reactive oxygen species (ROS) play a major role in the management of the normal wound-healing process and harmfully affect cells and tissues [3]. Antioxidant products may lead to control wound oxidative stress and promote wound healing by shortening the healing time span [4].

Several attempts have been made to find drugs in traditional medicine to promote the healing of skin lesions. U. dioica, often called "nettle" or "stinging nettle," is a herbaceous perennial flowering plant belonging to Urticaceae family and growing in the temperate zones of Asia, America, North Africa, and Europe [5]. Some scientists have studied the chemical composition of U. dioica and reported that its leaves contained a wide variety of chemical constituents such as minerals, vitamins, amino acids, flavonoids, sterols, phenolics, and fatty acids, which have beneficial effects on human health [6-9]. GC-MS analysis of U. dioica methanolic leaf extract showed the presence of cinnamic acid, coumarins, and homovanillic acid as phenolic compounds. The HPLC analysis of the extract also evidenced the presence of abundant [beta]-carotenes and chlorophyll [10].

U. dioica was frequently used by humans for many medicinal purposes. In the home remedies, the nettle has been used as a source of medicinal preparations. Thanks to its antihemorrhagic effect, the powdered leaf extract was traditionally used to reduce nose bleeding and excessive menstrual flow [10]. This plant has been used for the treatment of rheumatism, arthritis, anemia, and prostate diseases in the folk medicine [11]. Several clinical and experimental studies investigated the U. dioica and suggested that nettle herb has some pharmacological properties such as antiinflammatory [12], antibacterial, antioxidant, hypoglycemia [13], and antiviral activities [14]. U. dioica has a long use record in the external treatment of skin problems. Nevertheless, no published work was undertaken justifying its wound-healing effect.

It was reported that the wound-healing efficiency requires the integration of many biological activities such as antioxidant and antibacterial properties of a plant extract [1]. This work therefore aimed to (i) explore the in vivo wound-healing activity of the Tunisian U. dioica with reference to its antioxidant and antimicrobial effects; (ii) characterize the phytochemical composition of the used extract by GC-MS; and (iii) analyze the relationship between its chemical composition and bioactivities.

2. Materials and Methods

2.1. Plant Drug Extraction. U. dioica fresh leaves were collected from Sfax (Tunisia, 35[degrees]14,58.36,, N, +11[degrees]7,17.75,, E) in February 2015 and the authentication was achieved agreeing to the flora of Tunisia. The plant was identified by the Pr. Mohamed Chaieb, botanist at the University of Science (Sfax, Tunisia) and a voucher specimen (LBPes UD 02.15) was deposited in the herbarium of the Laboratory of Biopesticides of the Centre of Biotechnology of Sfax.

The U. dioica dried leaves (100 g) were clipped into small parts with a blender and were macerated in ethanol-water (8: 2, v/v) for 48 h to yield EtOH-[H.sub.2]OE. Then the extract was filtered using Whatman paper. The dried hydroethanolic crude extract (20 g) was sequentially partitioned into two solvents with increasing polarity: n-hexane and ethyl acetate. The organic solvents were evaporated at reduced pressure (Rotary Evaporator Buchi R-200, Switzerland) and the water fraction was lyophilized. Three fractions were thus obtained: hexanic fraction (n-Hex-F), ethyl acetate fraction (EtOAc-F), and water fraction (W-F) of U. dioica.

The stock solutions were kept at 4[degrees]C in the dark until a further analysis.

2.2. Gas Chromatography-Mass Spectrometry (GC-MS)

Analysis of Phytosterols and Fatty Acids

2.2.1. Saponification and Extraction. U. dioica EtOH-[H.sub.2]OE was saponified with 50 ml methanolic potassium hydroxide (2N) for 1h (under reflux) and then extracted three times with 100 ml hexane. The solvent was removed and concentrated in 1 ml n-hexane prior to the GC-MS analysis of terpenes and sterols. For the fatty acids analysis, using the N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) a step of silylation was used prior to GC-MS analysis. BSTFA (200 [micro]l), 200 [micro]l extract of U. dioica EtOH-[H.sub.2]O in acetonitrile, and 50 [micro]l of pyridine were mixed and mechanically shaken for 2 min. The sample was placed in a water bath, at 80[degrees]C for 60 min, and then analyzed by GC-MS.

2.2.2. GC-MS Identification. An Agilent 6890N Network GC system (Agilent Technologies) equipped with HP-5MS fused silica capillary column (30 m x 0.25 mm i.d. x 0.25 [micro]m film thickness) supplied by Agilent and coupled to a mass selective detector (MSD5973, ionization voltage 70 eV; all Agilent, Santa Clara, France) was used. Helium was used as a carrier gas at 1 ml/min flow rate. The GC oven temperature was held at 60[degrees]C for 2 min and then programmed to rise from 60 to 300[degrees]C at a rate of 5[degrees]C/min. The split/splitless injector (splitless mode) temperature was set to 280[degrees]C. The components were identified by careful examination of fragmentation patterns [15] and spectral data obtained from the Wiley and NIST libraries. Determination was carried out in duplicate.

2.3. Total Phenolic Content Determination. Total phenolic content was determined using the Folin-Ciocalteu method adapted to a microscale described by Waterman and Mole [16]. Gallic acid was used as a standard. The absorbance was measured at 760 nm and the results were expressed as mg of gallic acid equivalent per g of dry weight (mg GAE/g). Tests were performed in triplicate for each extract.

2.4. Determination of Total Flavonoids Content. The extracts total flavonoid content was assessed by the aluminum chloride spectrophotometric method [17]. The mixture absorbance was measured at 430 nm. The result of flavonoid content was expressed as mg of Quercetin equivalent per g dry weight (mg QE/g). Tests were performed in triplicate for each extract.

2.5. In Vitro Antioxidant Testing Assay. The free radical-scavenging activity and the capacity of the hydroalcoholic extract and derived fractions to ovoid [beta]-carotene bleaching were measured, respectively, in triplicate using the methods described by Kirby and Schmidt [18] and Pratt [19]. The ascorbic acid and the Butylated hydroxyanisole (BHT) were taken as references.

2.6. Antibacterial Activity. The U. dioica organic extracts antibacterial effects were verified against two Gram-positive (Staphylococcus aureus ATCC 25923 and Bacillus subtilis ATCC14579) and two Gram-negative (Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 9027) bacteria. The bacterial strains were cultivated in Mueller-Hinton agar (MH) (Oxoid Ltd., UK) at the appropriated temperature for each strain for 24 hours. For the antibacterial activity, a freshly inoculum was prepared from isolated strains. Culture were maintained on Muller-Hinton agar slants at 4[degrees]C as stock cultures and subcultured once in 2 weeks.

The antimicrobial screening was performed using the agar well diffusion method according to Guven et al. [20] in triplicate. Minimum inhibitory concentrations (MIC) of U. dioica extracts were determined according to Eloff [21]. Microdilution test was performed in sterile 96-well microplates using 100 [micro]L/well. The final extracts concentrations in each well ranged from 0.156 to 10mg/mL. The MIC was the lowest concentration of extracts at which the microorganism does not demonstrate visible growth after incubation. As an indicator of bacterial growth, 25 [micro]l of piodonitrotetrazolium chloride INT (0.5mg/mL) dissolved in sterile water was added to the wells and incubated at 37[degrees]C for 30 min.

3. In Vivo Wound-Healing Activity Study

3.1. Preparation of U. dioica Extract. The EtOH-[H.sub.2]OE (yield = 20.6%) was dissolved at a concentration of 10% in sterile solution of glycerol and stirred until a homogeneous ointment was obtained. A dosage of 50 [micro]l/[mm.sup.2] of the U. dioica extract from this ointment was topically administered on the wound.

3.2. Animals. Wistar rats (160-180 g) of either sex were obtained from Central Pharmacy of Tunisia (SIPHAT, Tunisia). The animals were housed under standard laboratory conditions at a temperature of 22 [+ or -] 2[degrees]C. They were kept in individual cages with food and water ad libitum. All experiments were conducted in accordance with the European Community guidelines (EEC directive of 1986; 86/609/EeC) for the care and use of laboratory animals and approved by the Committee of Animal Ethics (Directive 2001-2133) issued by the University of Sfax Tunisia.

3.3. Excision Wound Model. The backs of twenty-four rats were sterilized and shaved under anaesthesia (ketamine 100 mg/Kg body weight) before circular wound creation. Full thickness of predetermined dorsal region of rats was then carefully cut [22]. The period of epithelialization and wound contraction were noted. Wound contraction was measured as contraction rate each 2 days after wound induction. A specimen sample of tissue from the healed wounds was collected for histopathological examination.

3.4. Wound-Healing Activity. Animals with a mean weight of 160 g were split into four groups (n = 5): Group I: rats were just cleaned with saline solution (control group), Group II: rats were treated with glycerol (control group), Group III: rats were treated with a reference drug "CICAFLORA cream" (positive control), and Group IV: wounds were treated with 50 [micro]L/[mm.sup.2] of EtOH-[H.sub.2]OE of U. dioica.

The treatments were topically applied and carried out each two days using sterilized compresses immediately after wound induction till the first group completely healed.

3.5. Bleeding Time in Rats. Adult Wistar rats of both sexes were divided into 3 groups (n = 6). The tip of the tail of each rat was cut with a scalpel blade to cause bleeding. As soon as the animal began to bleed a stopwatch was started simultaneously with the application of the test substance on the cut. The control group clipped tails were immersed in distilled water or normal saline solution. The tested group clipped tails were dipped in the hydroalcoholic extract of U. dioica. All the tails were vertically positioned on top of the blotting paper to wipe off blood. Stopwatch was stopped and bleeding time was recorded as soon as bleeding ended [23].

4. Wound-Healing Evaluation Parameters

4.1. Measurement of Wound Area. The wound areas were traced on transparency paper each two days. The wound surface areas were then measured using a software application (AutoCAD 2015) for design and drafting.

Wound contraction, expressed as a reduction of the original wound size, was calculated using the following equation:

Wound closure (%) = [([A.sub.0] - [A.sub.d])/[A.sub.0]] x 100, (1)

where [A.sub.0] and [A.sub.d] are the initial wound area (day 0: wounding day) and wound area on day (d), respectively.

4.2. Chromatic Study. A chromatic code was attributed to each wound as follows: bright red = blood covering the wound; dark red = coagulation of blood in the epidermis; red = granulation tissue; and pink = epithelialization step [24].

4.3. Wound Contraction and Epithelialization Time. This was estimated by observing the number of days necessary for the scab to drop off from the wound surface [25].

4.4. Hydroxyproline Estimation. The estimation of hydroxyproline content was achieved according to Bergman and Loxley [26] and results were reported as mg/g dry weight of tissue.

4.5. Histological Examination. Tissue specimen samples from wound site of all studied groups were tacked and fixed in 10% neutral buffered formalin solution, embedded in paraffin wax, and cut and stained with hematoxylin and eosin. The sections were observed under a light microscope regarding fibroblast proliferation, collagen formation, angiogenesis, and epithelialization.

4.6. Statistical Analysis. Data were expressed as mean values [+ or -] standard deviation (SD). A statistical significance comparison between groups was accomplished using the SPSS version 20.

The mean differences between the different groups were assessed by Duncan test and compared by one-way analysis of variance (ANOVA). Differences were considered significant at P < 0.05.

5. Results

5.1. Phytochemical Screening and Antioxidant Activity of U. dioica. Total phenolic and flavonoid contents and the antioxidant activity of the different U. dioica organic extracts are shown in Table 1. Phytochemical screening of EtOH-[H.sub.2]OE of U. dioica leaves and their fractions showed that alkaloids, tannins, polyphenols, and flavonoids are more abundant in the EtOH-[H.sub.2]OE than the leave fractions. Indeed, the EtOH-[H.sub.2]OE had the highest amount of phenolic compounds (116.9 [+ or -] 5.416 mgGAE/g) and flavonoids (43 [+ or -] 0.019 mgEQ/g) followed by the EtOAc-F (23.15 mg GAE/g and 33.2mgEQ/g, resp.). The increased amount of polyphenolic compounds in the EtOH-[H.sub.2]OE was coupled with the best antioxidant activity in the DPPH and [beta]-carotene bleaching test assays. EtOH-[H.sub.2]OE of U. dioica showed DPPH scavenging activity with a prominent IC50 value of 10.4 [micro]g/mL when compared to ascorbic acid (3.5 [micro]g/mL) a well-known antioxidant. The oxidation was effectively inhibited, in the [beta]-carotene linoleic acid assay, by the EtOH-[H.sub.2]O plant extract. The I[C.sub.50] value was 15 [micro]g/mL compared to BHT (5 [micro]g/mL) taken as reference.

5.2. U. dioica EtOH-[H.sub.2]OE GC-MS Analysis. The fatty acids (FAs) results and sterol composition were depicted in Table 2. Numerous fatty acids were detected in EtOH-[H.sub.2]OE of U. dioica. The main identified polyunsaturated fatty acids were palmitoleic ([C.sub.16:1]), oleic ([C.sub.18:1]), linoleic ([C.sub.18:2]), and linolenic ([C.sub.18:3]).

The EtOH-[H.sub.2]OE of U. dioica leaves analysis revealed the presence of a high amount of polyunsaturated fatty acids known as essential fatty acids (37.85% of the total FAs). Palmitic acid, the most common saturated fatty acid and the precursor of unsaturated fatty acids, was present at a considerable rate (13.53%). In Table 2, lupeol, a triterpene, accounted for about 86% of the total sterols.

5.3. Antibacterial Activity. The U. dioica organic extracts antibacterial activity was qualitatively assessed against tested microorganisms (two Gram-negative and two Gram-positive bacteria species) according to inhibition zones and the determination of the Minimum Inhibitory Concentrations (MIC). The results are represented in Table 3.

Among the tested extracts, only EtOH-[H.sub.2]OE and EtOAcF exhibited an antibacterial activity. The best activities were recorded against Pseudomonas aeruginosa (20 [+ or -] 0.2 mm) and Enterococcus faecalis (18 [+ or -] 0.6 mm) in the EtOH-[H.sub.2]OE with the lowest MIC values of 0.312 and 1.25 mg/mL, respectively. n-Hexane and water fractions remained inactive in the range of the studied concentrations (2.5 mg/wells).

5.4. Bleeding Time in Rats. The bleeding time in rats' data revealed that the best reduction was observed with EtOH-[H.sub.2]OE of U. dioica. According to this test, the bleeding time significantly decreased (P < 0.001) in the group treated with EtOH-[H.sub.2]OE (4.83[+ or -]0.44 sec) compared to the untreated group (112.66 [+ or -] 2.51 sec) and positive control group (36 [+ or -] 2.2 sec).

5.5. Wound-Healing Evaluation Parameters

5.5.1. Body Weight. Body weight changes are listed in Table 4. Our findings revealed an insignificant increase of rats' weight after treatment in all the studied groups. However, these disparities did not reveal a difference in the mean body weight between all groups of rats at the end of the experimental period.

5.5.2. Chromatic Study. The wound-healing activity was assessed, each two days, by a chromatic study based on the progressive changes in wound color during the different wound-healing phases. The photos of the wound appearance, of the four tested groups, are illustrated in Table 7.

The chromatic study showed similar coloration of the wound in the first 2 days for the four studied groups: a bright red color (corresponding to the blood covering the wound) during the first day and a dark red color in the second day. By the third day, the untreated and glycerol treated groups showed a large inflammatory rim around the injuries with increased amounts of exudates. From the third day, a brown color scab was detected in the U. dioica treated group and towards day 7 for "CICAFLORA" treated group. This scab persisted in all the treated groups from day 7 to day 9 of the experiment. By day 9, an erythema around the damaged skin of the untreated wounds was shown.

After 11 days, scabs had exfoliated in the U. dioica treated group showing pink blade coloration but the reference drug group wounds persisted to be open and showed just residual scab. However, these scabs still persisted in the untreated and glycerol treated groups and showed open wounds.

5.5.3. Assessment of Wound Closure. The healing process was examined during the 11-day experimental period to appraise the wound-healing ability of the tested extract by following the wound closure rate. The results were compared to "CICAFLORA cream" a standard reference drug. This repairing drug contains 10% of Mimosa tenuiflora extract as the main active component. This rate was evaluated for each group by determining the closed injuries as a function of time. The rate measure of the wound closure of all groups is presented in Table 5.

As expected, significant wound-healing activity was showed in CICAFLORA and U. dioica treated groups compared with glycerol and control groups (Table 5). The untreated group showed the lower wound closure than the treated ones (P < 0.001). The rate of wound closure in the rats treated with EtOH-[H.sub.2]OE of U dioica was 74.45% on 9th day and 92.39% on 11th day, respectively. As shown in Table 5, the untreated wounds healed much more slowly.

At the end of experiment, by day 11 of the treatment, almost all the wounds treated with U. dioica showed complete wound closure (92.39%) against only 85.36% of wound healing recorded in CICAFLORA. The untreated rats still exhibited unhealed open injuries at the end of the experiment (60.91%). Thus, the mean time taken for reepithelization of the excision wound in EtOH-[H.sub.2]OE of U. dioica treated group was less compared to the animals treated with the reference drug.

5.5.4. Estimation of Hydroxyproline Content. Hydroxyproline is an amino acid specific of collagen. As reported in Table 6, the hydroxyproline level increased in the group treated with U. dioica (25.9 mg/100 mg of tissue) when compared to the untreated group (18.97 mg/100 mg of tissue) and CICAFLORA (22.68 mg/100 mg of tissue) treated groups (P < 0.05).

5.5.5. Histopathological Study. On the last day of treatment (day 11) histological observations were performed on samples. They are displayed in Figure 1.

The biopsies from tissues were evaluated for reepithelization, revascularizations, fibroblasts, and inflammatory cells. The histological study of the granulation tissue of the untreated and glycerol treated groups showed incomplete epithelial regeneration (Figures 1(a) and 1(b)), respectively. Further, numerous inflammatory cells and many immature fibroblasts were shown in the untreated groups. However, biopsies from the U. dioica treated rats (Figure 1(c)) showed significant neovascularization, a clearly identified thick epidermis, and fibroblasts. The boundary layer between the epidermis and the dermis was clear. Biopsies from the reference group "CICAFLORA" showed no epidermal layer or an incomplete one and considerable inflammatory cells (Figure 1(d)). Also, the presence of fibroblasts in the dermis indicated completion of healing. The reference drug and the control groups exhibited delayed wound-healing process compared to that of U. dioica treated group.

6. Discussion

Plants have rich medicinal value and potential sources of new wound-healing compounds. Nowadays, plant extracts are viewed as an efficient alternative for wound healing thanks to their widespread availability. The wound healing is a highly complex mechanism of repair following injury. During the healing process, an inflammatory response occurs leading to the generation of ROS well known for their noxious effect. Furthermore, an infection by S. aureus and P. aeruginosa can delay the inflammatory phase and disrupt the normal clotting system hence delaying the angiogenesis. The improved wound-healing effects of various plant extracts may be attributed to the antioxidant and antimicrobial properties of their phyto constituents. A positive role has been shown between free radical-scavenging action and wound-healing process [27]. In the current study, the EtOH-[H.sub.2]OE of U. dioica was found to have remarkable antioxidant and antibacterial activities in vitro. The phytochemical analysis of EtOH-[H.sub.2]OE of U. dioica showed the richness of this extract in phenolic and flavonoid compounds. The positive correlation between total phenolics content and antioxidant activity ([R.sup.2] = 0.96) of U. dioica extract explains the ROS scavenging capacity [28]. Furthermore, the U. dioica extract exerts antibacterial effects, against Gram-positive and negative bacteria such as S. aureus and P aeruginosa known as the commonest strains associated with open wound infections [29]. The richness of U. dioica EtOH-[H.sub.2]OE in phenolics, known for their powerful antioxidant and antibacterial properties, also involved in modulation of hemostasis and reduction of healing time [30-32], prompted us to assess the homeostatic and wound-healing effects of U. dioica on rat skin wound-healing model. According to the primary homeostasis test, the extract has significantly (P < 0.001) shortened the bleeding time by boosting blood clotting. This result suggests that this extract contains some phytochemical compounds with antiplatelet and fibrinolytic activities which could contribute to the healing process [33].

The investigation of the rats' body weights of the studied groups during the experimental period showed their normal growth suggesting that the used extract had no side effects on rats. The morphometric assessment showed increased contraction rates of the wounds from the treated groups than in the untreated ones. Additionally, wound area decreased significantly in U. dioica treated group on day 11 (P < 0.01). Previous research using the same wound model and ethanolic extract of Sida cordifolia has reported that complete wound closure was observed within 14 days [34]. However, it is clearly observed that it was shortened to 11 days in the current study.

Visual observations revealed that granulation tissue was observed earlier in the treated injuries compared to the control ones. This proves that topical use of U. dioica extract was found to be equivalent to the reference cream in the advancement of granulation tissue formation. The histological study of granulation tissue of untreated animals demonstrated an invasive macrophage migration with limited collagen fibers compared to the treated ones. However, healed biopsies of U. dioica treated rats exhibited a granulation tissue with a significant increase in collagen content with more fibroblasts, small new blood vessel, and fewer inflammatory cells. A significant enhancement in collagen deposition was observed during the wound-healing process in U. dioica treated group due to the increased migration of fibroblasts and epithelial cells to the wound area. The reduced collagen density in the untreated group might be due to a persistent inflammatory stage where the degradation of collagen will exceed its synthesis [35]. Moreover, a higher level of hydroxyproline, a molecule involved in collagen formation and wound healing, was revealed in U. dioica treated group compared to that in the untreated group. This implies an increased collagen turnover.

Moreover, the tested extract showed the presence of alkaloids which are involved in reepithelialization process, a crucial step towards wound healing [36]. The richness of U. dioica extract in alkaloids, tannins, polyphenols, and flavonoids may also synergistically promote angiogenesis. Hoeben et al. [37] have previously reported a significant relationship between phytochemical composition of plant extract and the neoformation of microvessels in the wound-healing process. It was also reported that polyphenols can regulate angiogenesis in vivo and proliferation of epithelial cells in vitro [38]. All these findings are in agreement with the histological observations after topical application of the tested extract with thin epithelium, organized collagen fibers, and omitted inflammatory cells. Interestingly, the morphological evaluation on day 11 revealed that the wounds treated with U. dioica were relatively clean and free from any inflammatory reaction compared to the negative control groups with damaged skin and pus accumulation. Several studies have previously demonstrated the wound-healing activity of medicinal plants. The extract of Ocimum sanctum significantly increased the wound breaking strength by faster epithelialization and increased wound contraction rate [39]. Ammar et al. [40] showed that wounds treated with methanolic extract of Opuntia ficus-indica contain more collagen deposition and fewer inflammatory cells and angiogenesis which were in accordance with our data. Our results revealed that the U. dioica treated group healed faster and showed less scarring, more blood capillaries, less inflammatory cells, and more fibroblasts and collagen. Thus, the U. dioica enhances the wound-healing process by increasing the rate of various phases, such as cell proliferation, angiogenesis, and collagen formation.

The GC-MS analysis of EtOH-[H.sub.2]OE of U. dioica showed the highest level of lupeol in this extract. Previous reports have evaluated the efficiency of lupeol in the wound-healing process and reported that lupeol isolated from the Celastrus paniculatus extract improved reepithelization, with an enhancement of granulation tissue and collagen [41]. Moreover, recent observations highlighted the anti-inflammatory effects of phytosterols which can stimulate new skin growth by attracting macrophages and enhancing fibroblast and collagen deposition [42]. On the other hand, the tested extract contained a significant amount of unsaturated fatty acids (37.85%) such as the palmitoleic, oleic, linoleic, and linolenic acids. It was stated that fatty acids agents accelerate the healing of wounds thanks to their proinflammatory effect [43]. Thus, they increase angiogenesis, cell proliferation, and collagen formation and contribute to the antibacterial activity [44].

Wound-healing efficacy of U. dioica EtOH-[H.sub.2]OE observed in this work originates most probably from a synergistic interaction between its antioxidant capacity and antibacterial property owing to its richness in various effective chemical compounds present in the extract such as phenolics, fatty acids, and lupeol.

7. Conclusion

The present study revealed that the hydroalcoholic extract obtained from U. dioica has a significant wound-healing activity which was evident by the increased rate of wound contraction and reduction in the period of epithelialization and angiogenesis. The total extract richness in various chemical compounds and the antioxidant and antibacterial capacities clearly contributed to its medicinal properties. However, the identification and elucidation of active components in this plant may provide useful knowledge and lead to the development of new and effective drugs against wounds. The combination of traditional and modern knowledge can produce better drugs for wound healing with fewer side effects. The results obviously highlight the health uses of this traditional plant for future clinical applications.

Conflicts of Interest

The authors have declared that there are no conflicts of interest.


This work was supported by grants from the Tunisian Ministry of Higher Education and Scientific Research.


[1] S. M. Ezzat, M. A. Choucry, and Z. A. Kandil, "Antibacterial, antioxidant, and topical anti-inflammatory activities of Bergia ammannioides: A wound-healing plant," Pharmaceutical Biology, vol. 54, no. 2, pp. 215-224, 2016.

[2] T. Kondo and Y. Ishida, "Molecular pathology of wound healing," Forensic Science International, vol. 203, no. 1-3, pp. 93-98, 2010.

[3] E. Aliyev, U. Sakallioglu, Z. Eren, and G. Acikgoz, "The effect of polylactide membranes on the levels of reactive oxygen species in periodontal flaps during wound healing," Biomaterials, vol. 25, no. 19, pp. 4633-4637, 2004.

[4] A. Martin, "The use of antioxidants in healing," Dermatologic Surgery, vol. 22, no. 2, pp. 156-160, 1996.

[5] A. T. Borchers, C. L. Keen, J. S. Stern, and M. E. Gershwin, "Inflammation and Native American medicine: The role of botanicals," American Journal of Clinical Nutrition, vol. 72, no. 2, pp. 339-347, 2000.

[6] R. Upton, "Stinging nettles leaf (Urtica dioica L.): Extraordinary vegetable medicine," Journal of Herbal Medicine, vol. 3, no. 1, pp. 9-38, 2013.

[7] S. K. Dugenci, N. Arda, and A. Candan, "Some medicinal plants as immunostimulant for fish," Journal of Ethnopharmacology, vol. 88, no. 1, pp. 99-106, 2003.

[8] J. L. Guil-Guerrero, M. M. Rebolloso-Fuentes, and M. E. Torija Isasa, "Fatty acids and carotenoids from Stinging Nettle (Urtica dioica L.)," Journal of Food Composition and Analysis, vol. 16, no. 2, pp. 111-119, 2003.

[9] S. Otles and B. Yalcin, "Phenolic compounds analysis of root, stalk, and leaves of nettle," The Scientific World Journal, vol. 2012, Article ID 564367, 2012.

[10] M. Ahmed Kk and S. Parsuraman, "Urtica dioica L., (Urticaceae): A stinging nettle," Systematic Reviews in Pharmacy, vol. 5, no. 1, pp. 6-8, 2014.

[11] S. Vogl, P. Picker, J. Mihaly-Bison et al., "Ethnopharmacological in vitro studies on Austria's folk medicine--An unexplored lore in vitro anti-inflammatory activities of 71 Austrian traditional herbal drugs," Journal of Ethnopharmacology, vol. 149, no. 3, pp. 750-771, 2013.

[12] J. E. Chrubasik, B. D. Roufogalis, H. Wagner, and S. A. Chrubasik, "A comprehensive review on nettle effect and efficacy profiles, part I: herba urticae," Phytomedicine, vol. 14, no. 6, pp. 423-435, 2007.

[13] A. Ahangarpour, M. Mohammadian, and M. Dianat, "Antidiabetic effect of hydroalcholic urtica dioica leaf extract in male rats with fructose-induced insulin resistance," Iranian Journal of Medical Sciences, vol. 37, no. 3, pp. 181-186, 2012.

[14] R. E. Uncini Manganelli, L. Zaccaro, and P. E. Tomei, "Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.," Journal of Ethnopharmacology, vol. 98, no. 3, pp. 323-327, 2005.

[15] L. J. Goad and T. Akihisa, Analysis of Sterols, Blackie Academic and Professional, London, UK, 1997.

[16] P. Mueller, "The quantitative analysis of plant growth: Studies in ecology Vol. 1, by G. Clifford Evans. Pp xxvi + 734. Blackwell Scientific Publications, Oxford. 1972. E8a50," Endeavour, vol. 32, no. 116, p. 96, 1973.

[17] C. Quettier-Deleu, B. Gressier, J. Vasseur et al., "Phenolic compounds and antioxidant activities of buckwheat (Fagopyrum esculentum Moench) hulls and flour," Journal of Ethnopharmacology, vol. 72, no. 1-2, pp. 35-42, 2000.

[18] A. J. Kirby and R. J. Schmidt, "The antioxidant activity of Chinese herbs for eczema and of placebo herbs--I," Journal of Ethnopharmacology, vol. 56, no. 2, pp. 103-108, 1997.

[19] D. E. Pratt, "Natural antioxidants of soybean and other oilseeds," in Autoxidation in Food and Biological Systems, M. G. Simic and M. Karel, Eds., pp. 283-292, 1980.

[20] K. Guven, E. Yucel, and F. Cetintas, "Antimicrobial activities of fruits of Crataegus and Pyrus species," Pharmaceutical Biology, vol. 44, no. 2, pp. 79-83, 2006.

[21] J. N. Eloff, "A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria," Planta Medica, vol. 64, no. 8, pp. 711-713, 1998.

[22] L. Suguna, S. Singh, P. Sivakumar, P. Sampath, and G. Chandrakasan, "Influence of Terminalia chebula on dermal wound healing in rats," Phytotherapy Research, vol. 16, no. 3, pp. 227231, 2002.

[23] C. O. Okoli, P. A. Akah, and A. S. Okoli, "Potentials of leaves of Aspilia africana (Compositae) in wound care: An experimental evaluation," BMC Complementary and Alternative Medicine, vol. 7, article no. 24, 2007.

[24] L. Teot, S. Meaume, and O. Dereure, "Plaies et cicatrisations au quotidian," Sauramps Medical, p. 351, 2001.

[25] A. N. Rashed, F. U. Afifi, and A. M. Disi, "Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1," Journal ofEthnopharmacology, vol. 88, no. 2-3, pp. 131-136, 2003.

[26] I. Bergman and R. Loxley, "Two improved and simplified methods for the spectrophotometric determination of hydroxyproline," Analytical Chemistry, vol. 35, no. 12, pp. 1961-1965, 1963.

[27] I. Siintar, E. K. Akkol, L. Nahar, and S. D. Sarker, "Wound healing and antioxidant properties: do they coexist in plants?" Free Radicals and Antioxidants, vol. 2, no. 2, pp. 1-7, 2012.

[28] S. D. Fitzmaurice, R. K. Sivamani, and R. R. Isseroff, "Antioxidant therapies for wound healing: a clinical guide to currently commercially available products," Skin Pharmacology and Physiology, vol. 24, no. 3, pp. 113-126, 2011.

[29] M. N. Swartz, "Subcutaneous tissue infections and abscesses," in Principles and Practice of Infectious Diseases, G. Mandell, R. Douglas, and V. Bennett, Eds., 818, p. 808, Churchill Livingstone Inc, New York, NY, USA, 1990.

[30] S. Banerjee, S. Manna, P. Saha, C. K. Panda, and S. Das, "Black tea polyphenols suppress cell proliferation and induce apoptosis during benzo(a)pyrene-induced lung carcinogenesis," European Journal of Cancer Prevention, vol. 14, no. 3, pp. 215-221, 2005.

[31] T. Okuda, "Systematics and health effects of chemically distinct tannins in medicinal plants," Phytochemistry, vol. 66, no. 17, pp. 2012-2031, 2005.

[32] R. A. F. Clark, Cutaneous Wound Repairs, Oxford University, New York, NY, USA, 1991.

[33] S. C. Akomas and S. N. Ijioma, "Bleeding and clotting time effect of ethanolic extracts of Chromolaena odorata versus Ocimum gratissimum treated albino rats," Comprehensive journal of medical sciences, vol. 2, pp. 9-13, 2014.

[34] R. S. Pawar, P. K. Chaurasiya, H. Rajak, P. K. Singour, F. A. Toppo, and A. Jain, "Wound healing activity of Sida cordifolia Linn. in rats," Indian Journal of Pharmacology, vol. 45, no. 5, pp. 474-478, 2013.

[35] S. Sasidharan, S. Logeswaran, and L. Y. Latha, "Wound healing activity of Elaeis guineensis leaf extract ointment," International Journal of Molecular Sciences, vol. 13, no. 1, pp. 336-347, 2012.

[36] J. Fetse, J. Kyekyeku, E. Dueve, and K. Mensah, "Wound Healing Activity of Total Alkaloidal Extract of the Root Bark of Alstonia boonei (Apocynacea)," British Journal of Pharmaceutical Research, vol. 4, no. 23, pp. 2642-2652, 2014.

[37] A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. T. van Oosterom, and E. A. de Bruijn, "Vascular endothelial growth factor and angiogenesis," Pharmacological Reviews, vol. 56, no. 4, pp. 549-580, 2004.

[38] D. Umeda, S. Yano, K. Yamada, and H. Tachibana, "Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor," The Journal of Biological Chemistry, vol. 283, no. 6, pp. 3050-3058, 2008.

[39] S. L. Udupa, S. Shetty, A. L. Udupa, and S. N. Somayaji, "Effect of Ocimum sanctum Linn. on normal and dexamethasone suppressed wound healing," Indian Journal of Experimental Biology (IJEB), vol. 44, no. 1, pp. 49-54, 2006.

[40] I. Ammar, S. Bardaa, M. Mzid et al., "Antioxidant, antibacterial and in vivo dermal wound healing effects of Opuntia flower extracts," International Journal of Biological Macromolecules, vol. 81, pp. 483-490, 2015.

[41] B. G. Harish, V. Krishna, H. S. Santosh Kumar, B. M. Khadeer Ahamed, R. Sharath, and H. M. Kumara Swamy, "Wound healing activity and docking of glycogen-synthase-kinase-3-[beta]-protein with isolated triterpenoid lupeol in rats," Phytomedicine, vol. 15, no. 9, pp. 763-767, 2008.

[42] S. Loizou, I. Lekakis, G. P. Chrousos, and P. Moutsatsou, "[beta]- Sitosterol exhibits anti-inflammatory activity in human aortic endothelial cells," Molecular Nutrition & Food Research, vol. 54, no. 4, pp. 551-558, 2010.

[43] L. M. Pereira, E. Hatanaka, E. F. Martins et al., "Effect of oleic and linoleic acids on the inflammatory phase of wound healing in rats," Cell Biochemistry & Function, vol. 26, no. 2, pp. 197-204, 2008.

[44] J. Hinton A. and K. D. Ingram, "Use of oleic acid to reduce the population of the bacterial flora of poultry skin," Journal of Food Protection, vol. 63, no. 9, pp. 1282-1286, 2000.

Karama Zouari Bouassida, (1) Sana Bardaa, (2) Meriem Khimiri, (1) Tarek Rebaii, (3) Slim Tounsi, (1) Lobna Jlaiel, (1) and Mohamed Trigui (1)

(1) Laboratory of Biopesticides, Center of Biotechnology of Sfax, University of Sfax, P.O. Box 1177, 3018 Sfax, Tunisia

(2) Laboratory of Pharmacology, Faculty of Medicine of Sfax, Road Majida Boulila, 3028 Sfax, Tunisia

(3) Laboratory of Histopathology, Faculty of Medicine of Sfax, Road Majida Boulila, 3028 Sfax, Tunisia

Correspondence should be addressed to Karama Zouari Bouassida;

Received 19 June 2017; Accepted 12 September 2017; Published 17 October 2017

Academic Editor: Dong-Wook Han

Caption: Figure 1: The representative photomicrographs of the effect of the physiological serum (a); glycerol (b); U. dioica (c); and "CICAFLORA" (d) treatment on rat, showing epidermal and dermal architecture of wounds on the 11th day. HE-stained histological sections are 5 mm thick and photomicrographs are taken at 20x magnifications. Ep: epidermis; Der: dermis; V: blood vessels; inf: inflammatory cells; C: collagen.
Table 1: Amounts of total phenolic compounds, total flavonoids, and
determined I[C.sub.50] values of the DPPH free radical-scavenging
assay and [beta]-carotene bleaching test of U. dioica. Ascorbic acid
and BHT were used as standards.

Extract               Phenolic content (a)        content (a)
                         (mg GAE/g) (b)          (mg EQ/g) (c)

EtOH-[H.sub.2]OE      116.9 [+ or -] 5.416      43 [+ or -] 0.019
n. Hex-F                       ND                      ND
EtOAc-F               23.15 [+ or -] 2,674    33.2 [+ or -] 0,033
Water-F                8.8 [+ or -] 1.442     9.96 [+ or -] 0,018
Ascorbic acid                  --                       --
BHT                            --                       --

                           DPPH (a)         [beta]-Carotene (a)
Extract                 (I[C.sub.50]           (I[C.sub.50]
                         [micro]g/ml)           [micro]g/ml)

EtOH-[H.sub.2]OE      10.4 [+ or -] 0.001     15 [+ or -] 0.001
n. Hex-F              206 [+ or -] 0.106     210 [+ or -] 0,001
EtOAc-F               198 [+ or -] 0.054     175 [+ or -] 0.001
Water-F               286 [+ or -] 0.002     243 [+ or -] 0.001
Ascorbic acid          3.5 [+ or -] 0.2              --
BHT                           --               5.1 [+ or -] 0.1

(a) Each value represents the mean [+ or -] SD of three experiments;
(b): mg of gallic acid equivalent per g of dry plant extract; (c): mg
of Quercetin equivalent per g of dry plant extract; ND: not detected;
--: not tested.

Table 2: GC-MS analysis of fatty acids, terpenes, and sterols of the
U. dioica EtOH-[H.sub.2]OE.

Peak     Components                         Fatty acids (FAs)

1        Myristic acid                            C14:0
2        Pentadecanoic acid                       C15:0
3        Palmitic acid                            C16:0
5        Stearic acid                             C18:0
9        Arachidic acid                           C20:0
10       Behenic acid                             C22:0
         [SIGMA] saturated fatty acids

4        Palmitoleic acid                       C16:1 n-7
6        Oleic acid                             C18:1 n-9
7        linoleic acid                          C18:2 n-6
8        Linolenic acid                         C18:3 n-3
         [SIGMA] unsaturated Fatty acids
         Total fatty acids
                                              Esters of FAs
11       [beta]-Glyceryl oleate                 C18:1 n-9
12       [alpha]-Glyceryl oleate                C18:1 n-9
         [SIGMA] esters FAs
         Ni-compounds (a)

1        Lupeol                                     --
2        Neophytadiene                              --
3        Phytol                                     --
4        Stigma-4-en-3-one                          --
5        [beta]-Sitosterol                          --
         Total compounds
         Ni-compounds (a)

Peak      Retention       Relative
          time (min)     composition

         Saturated fatty acids (SFAs)

1           26.067           0.39
2           28.946           1.37
3           29.707          13.53
5           32.337          13.79
9           36.247           0.64
10          39.209           0.30
         Unsaturated fatty acids (SFAs)

4           30.182           1.29
6           32.676          24.33
7           33.301           10.4
8           34.154           1.83

11          37.016           0.44
12          37.122           0.14
             Terpenes and sterols

1           25.72           85.96
2           26.361           0.14
3           31.809           0.95
4           46.631           0.09
5           47.000           0.24

(a) Total of nonidentified compounds.

Table 3: Antibacterial activity of organic extracts of U. dioica
(inhibition diameter ZI in mm and MIC in mg/mL).


                                  ZI            MIC

S. aureus ATCC 25923         12 [+ or -] 0.1       5
E.faecalis ATCC29212         18 [+ or -] 0.6      1.25
P. aeruginosa ATCC 27853     20 [+ or -] 0.2     0.312
E. coli ATCC 25922                  0              ND


                                   ZI            MIC

S. aureus ATCC 25923         10 [+ or -] 0.4       5
E.faecalis ATCC29212          12 [+ or -]0.8      2.5
P. aeruginosa ATCC 27853            0              ND
E. coli ATCC 25922                  0              ND



S. aureus ATCC 25923         25 [+ or -] 0.8
E.faecalis ATCC29212         20 [+ or -] 0.2
P. aeruginosa ATCC 27853      18 [+ or -]0.5
E. coli ATCC 25922            21 [+ or -]0.9

Values are given as mean [+ or -] SD of triplicate experiment.
Gentamicin was used as a standard antibiotic at a concentration of 15
[micro]g/well; ND: not determined.

Table 4: Variation of the body weights of rats among the experimental

Day                        Group I                Group II

Before treatment      162 [+ or -] 1.58       163 [+ or -]4.39
After treatment       173 [+ or -] 3.66      173.8 [+ or -]4.02

Day                       Group III               Group IV

Before treatment       169 [+ or -]6.16       161 [+ or -]4.51
After treatment       178 [+ or -] 5.89      174 [+ or -] 6.21

Data are expressed as mean [+ or -] SD for weight of six rats in each
group. Means followed by the same column are not significantly
different at > 0.05. Group I was treated with physiologic serum
(negative control); Group II was treated with glycerol; Group III was
treated with "CICAFLORA cream" (positive control); and Group IV was
treated with the hydroalcoholic extract ofU. dioica.

Table 5: Effects of Urtica dioica and CICAFLORA on wound
contraction (%).

Days          0                3                          5

Group I     0.00     3.50 [+ or -] 0.14 (c)     7.19 [+ or -] 1.13 (d)
Group II    0.00     9.22 [+ or -] 0.68 (b)    16.62 [+ or -] 1.13 (c)
Group III   0.00     8.33 [+ or -] 1.13 (b)    31.56 [+ or -] 1.17 (b)
Group IV    0.00    12.36 [+ or -] 0.21 (a)    34.01 [+ or -] 1.14 (a)

Days                   7                          9

Group I      19.63 [+ or -] 0.34 (d)    30.63 [+ or -] 1.49 (d)
Group II     32.15 [+ or -] 0.84 (c)    49.73 [+ or -] 1.17 (c)
Group III    42.36 [+ or -] 0.35 (b)    62.18 [+ or -] 0.44 (b)
Group IV    48.97 [+ or -] 1.14 (a)     74.45 [+ or -] 0.94 (a)

Days                   11

Group I     60.91 [+ or -] 1.16 (d)
Group II     70.30 [+ or -] 0.31 (c)
Group III   85.36 [+ or -] 1.96 (b)
Group IV    92.39 [+ or -] 1.13 (a)

Values are given as mean standard deviation for groups of six rats
each. Data with different letters for each column represent
significant difference at P < 0.05. Group I was treated with the
physiologic serum (negative control); Group II was treated with
glycerol; Group III was treated with "CICAFLORA cream" (positive
control); and Group IV was treated with the hydroalcoholic extract of
Urtica dioica.

Table 6: Hydroxyproline content in different experimental animal
groups. All values are mean [+ or -] SD (n = 6/group).

Groups                  mg/100 mg of

Group I            18.97 [+ or -] 0.1 (c)
Group II              18.2 [+ or -] 0.3
Group III          22.68 [+ or -] 0.21 (b)
Group VI           25.90 [+ or -] 0.45 (a)

Group I was treated with physiologic serum (negative control); Group
II was treated with glycerol; Group III was treated with "CICAFLORA
cream" (positive control); and Group IV was treated with the
hydroalcoholic extract of U. dioica. (a,b,c) Different letters in the
same column indicate significant differences (a > b > c; P < 0.05).

Table 7: Representative photographs of macroscopic assessment of
wounds for the four studied groups on day 1, day 3, day 7, and day 11.

Days          Group I:       Group II:      Group III      Group IV:
              untreated       glycerol      CICAFLORA      U. dioica
                group         treated        treated        treated
                               group          group          group

Day 1

Day 3

Day 7
Day 9

Day 11

Group I was treated with physiologic serum (negative control); Group
II was treated with glycerol; Group III was treated with "CICAFLORA
cream" (positive control); and Group IV was treated with the
hydroalcoholic extract of U. dioica.
COPYRIGHT 2017 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Bouassida, Karama Zouari; Bardaa, Sana; Khimiri, Meriem; Rebaii, Tarek; Tounsi, Slim; Jlaiel, Lobna;
Publication:BioMed Research International
Article Type:Report
Date:Jan 1, 2017
Previous Article:Negative Correlation between miR-200c and Decorin Plays an Important Role in the Pathogenesis of Colorectal Carcinoma.
Next Article:Positive Effect of Higher Adult Body Mass Index on Overall Survival of Digestive System Cancers Except Pancreatic Cancer: A Systematic Review and...

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters